Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by lonc17on Dec 12, 2023 11:40pm
170 Views
Post# 35781409

RE:RE:RE:RE:RE:This has Anson Funds Mgmt fingerprints all over it.

RE:RE:RE:RE:RE:This has Anson Funds Mgmt fingerprints all over it.My guess is that Anson does not hold a single share of ONC.

I believe they shorted ONC in the six weeks leading up to the heavily discounted private placement.They used the PP to cover their short sales and they walked away from this seedy relationship with ONC forever.

ONC walked away with 15 million dollars so as to continue to pay MC and his c-suite buddies for another year.

The only reason that Anson may still be showing (as of last month) a holding is ONC would be due to shorting in other accounts and so on.

One need only read up a little on Anson and their legal challenges to quickly discover the corrupt business model they have created.

Of course, MC could have found this out with the click of a button. So it has to be the case that he knew who he was dealing with and said, "F the shareholders, let's take the money."

Hey Matt, don't forget to exercise those options tomorrow!

<< Previous
Bullboard Posts
Next >>